Longeveron Inc. Stock News

Longeveron Inc - Class A (LGVN) shares closed today 18.9% lower than it did at the end of yesterday. The stock is currently up 127.9% year-to-date, up 127.9% over the past 12 months, and up 127.9% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $19.25 and as low as $15.22 this week.Shares closed 69.6% below its 52-week high and 382.4% above its 52-week low.Trading volume this week was 17.4% lower than the 10-day average and 87.7% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -539.0% The company's stock price performance over the past 12 months beats the peer average by -527.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

NEW YORK, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQCM: SAVA)

Longeveron Inc. (NASDAQ:LGVN) with the stream of 8.89% also noticed, India Flotek Industries, Inc. (NYSE:FTK) encountered a rapid change of -9.24% in the last hour of Fridays trading session. Longeveron The post Miraculous Stock: Longeveron Inc. (NASDAQ:LGVN), Flotek Industries, Inc. (NYSE:FTK) appeared first on Stocks Equity .

Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates! The post The 10 Most Shorted Stocks Right Now for Friday, Dec.

During the last session, Longeveron Inc. (NASDAQ:LGVN)’s traded shares were 1.29 million. At the end of the trading day, the stock’s price was $15.97, reflecting an intraday loss of -7.85% or -$1.36. The 52-week high for the LGVN share is $45.00, that puts it down -181.78 from that peak though still a striking 82.22% gain … As The Stock Rises By 115.52% Year-To-Date, Longeveron Inc. (NASDAQ: LGVN)’S Stock Continues To Progress In 2021 Read More »

LGVN stock has soared in 2021 with the latest upbeat FDA news but a closer look at Longeveron's financials tells a different story. The post Why Longeveron's Good News Isn't Telling Us the Whole Truth

No, but make sure you understand what you''re getting into.

No, but make sure you understand what you're getting into.

Check out these biotech stocks turning heads in the stock market now.

These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months. The post 7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts appeared

Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy.

  Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS)  HLHS is a rare congenital heart defect that affects approximately 1,000 babies in the U.S. per yearOrphan Drug Designation confers certain benefits and may result in seven year market exclusivity upon approval for this indication if all statutory and regulatory requirements are metSupplements Rare Pediatric Disease Designation recently granted by FDA  Miami, Florida—Dec...

Longeveron Inc. (LGVN) with the stream of 11.78% also noticed, India Twitter, Inc. (TWTR) encountered a rapid change of -1.36% in the last hour of trading session. Longeveron Inc. (NASDAQ:LGVN) The post Glowing Stocks Review: Longeveron Inc. (NASDAQ:LGVN), Twitter, Inc. (NYSE:TWTR) appeared first on Stocks Equity .

The biotech stock is now up 171.5% year to date.

Stem cell therapies are back in vogue, at least for this Miami-based biotechnology company.